RH&PARTNER Investment Funds SICAV-RH&P Global Life Sciences Fund A Cap USD/ LU0115986761 /
| NAV15/05/2024 | Diferencia+2.5400 | Tipo de beneficio | Enfoque de la inversión | Sociedad de fondos |
|---|---|---|---|---|
| 169.2400USD | +1.52% | reinvestment | Equity Worldwide | FundPartner Sol.(EU) ▶ |
Rendimiento mensual
| ene. | feb. | mar. | abr. | may. | jun. | jul. | ago. | sep. | oct. | nov. | dic. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2002 | - | - | - | - | - | -15.05 | 0.14 | -6.70 | -4.24 | 8.10 | 4.10 | -9.97 | - |
| 2003 | -1.18 | -3.63 | 7.07 | 7.81 | 12.29 | -4.37 | 9.55 | -0.58 | -2.51 | -0.16 | -0.06 | 4.79 | +31.05% |
| 2004 | 5.08 | 3.18 | -2.19 | 1.73 | -2.81 | 0.29 | -8.29 | 2.21 | 5.19 | -1.36 | 1.35 | 5.05 | +8.87% |
| 2005 | -5.00 | -5.67 | -1.69 | 3.67 | 6.83 | 1.10 | 9.41 | 1.79 | 3.02 | -3.90 | 6.07 | 1.94 | +17.59% |
| 2006 | 4.13 | 2.71 | -2.26 | -3.30 | -2.81 | -1.98 | 2.17 | 1.05 | 0.57 | 5.05 | 2.01 | -2.98 | +3.95% |
| 2007 | 1.47 | -3.72 | 0.97 | 8.84 | -1.49 | -5.62 | -0.23 | -0.88 | 8.40 | 1.44 | -1.46 | -2.01 | +4.81% |
| 2008 | -3.47 | -1.52 | -0.14 | 4.47 | -0.74 | -0.53 | 11.71 | -1.42 | -5.78 | -18.16 | -5.08 | 8.90 | -14.03% |
| 2009 | -1.91 | -1.66 | -3.67 | -2.00 | -0.14 | 8.60 | 33.33 | -0.11 | 1.83 | -7.75 | 2.90 | 5.60 | +34.28% |
| 2010 | 1.74 | 5.34 | 18.75 | -5.27 | -12.05 | -1.62 | 3.47 | -1.47 | 9.17 | -1.25 | -1.50 | 13.25 | +27.88% |
| 2011 | -1.46 | -1.99 | 3.98 | 8.64 | 2.33 | -2.00 | -3.11 | -12.11 | -2.85 | -0.97 | -9.38 | 5.81 | -14.06% |
| 2012 | 14.60 | 0.65 | 5.57 | 5.46 | -4.27 | 2.47 | 1.25 | 0.64 | 5.71 | -7.15 | 5.99 | 0.03 | +33.56% |
| 2013 | 7.43 | 2.18 | 6.35 | 8.83 | 2.11 | -3.24 | 12.12 | -3.22 | 6.30 | -0.12 | 7.11 | 1.08 | +56.58% |
| 2014 | 6.73 | 9.27 | -9.15 | -2.81 | 3.37 | 4.82 | -0.34 | 11.77 | -1.60 | 7.91 | 2.06 | -1.61 | +32.51% |
| 2015 | 5.47 | 3.63 | 2.16 | -2.36 | 5.29 | -0.42 | 0.72 | -10.55 | -10.26 | 3.34 | 5.06 | 0.17 | +0.53% |
| 2016 | -23.39 | -3.31 | 4.41 | 3.79 | 4.00 | -6.25 | 10.71 | -4.53 | 2.71 | -12.42 | 7.48 | -3.50 | -22.82% |
| 2017 | 4.92 | 7.49 | 0.16 | 1.39 | -2.88 | 8.23 | 1.97 | 8.05 | -0.20 | -1.79 | 3.78 | -1.25 | +33.23% |
| 2018 | 11.89 | -4.50 | -1.92 | 0.40 | 3.74 | 0.19 | 4.94 | 5.80 | 0.43 | -16.48 | 3.99 | -11.47 | -6.23% |
| 2019 | 15.23 | 3.99 | 0.07 | -7.44 | -8.49 | 9.68 | -2.86 | -5.98 | -3.88 | 5.20 | 10.73 | 0.54 | +14.53% |
| 2020 | -5.54 | 0.87 | -5.79 | 14.86 | 5.46 | 2.85 | -0.93 | -3.45 | -1.99 | -4.24 | 7.13 | 1.97 | +9.68% |
| 2021 | 4.98 | -4.02 | -5.59 | 2.47 | -1.10 | 5.69 | -2.46 | 3.04 | -4.80 | -0.74 | -5.79 | 2.30 | -6.73% |
| 2022 | -8.90 | -2.21 | 3.43 | -8.08 | -0.61 | 0.91 | 2.72 | -2.39 | -4.10 | 8.79 | 6.84 | -1.38 | -6.37% |
| 2023 | 4.12 | -6.54 | 0.39 | -2.12 | -0.10 | -1.03 | 2.73 | -1.26 | -5.27 | -8.29 | 5.75 | 9.72 | -3.35% |
| 2024 | -2.94 | 1.23 | 2.45 | -5.10 | 5.71 | - | - | - | - | - | - | - | - |
Valores estimados
| Año hasta la fecha | 6 Meses | Promedio móvil | 3 Años | 5 Años | |
|---|---|---|---|---|---|
| Volatilidad | 14.08% | 15.28% | 15.26% | 20.49% | 23.18% |
| Índice de Sharpe | -0.08 | 1.48 | -0.36 | -0.37 | -0.15 |
| El mes mejor | +9.72% | +9.72% | +9.72% | +9.72% | +14.86% |
| El mes peor | -5.10% | -5.10% | -8.29% | -8.90% | -8.90% |
| Pérdida máxima | -8.98% | -8.98% | -16.46% | -31.19% | -35.08% |
| Rendimiento superior | -2.67% | - | 0.00% | -12.30% | -23.55% |
Todas las cotizaciones en USD
Tramos
| Nombre | Tipo de beneficio | Prec. de rescate | Promedio móvil | 3 Años | |
|---|---|---|---|---|---|
| RH&P Glob. Life Sciences Fd. I c... | paying dividend | 90.9900 | -3.06% | -14.56% | |
| RH&PARTNER Investment Funds SICA... | reinvestment | 85.5800 | -5.30% | -17.35% | |
| RH&PARTNER Investment Funds SICA... | reinvestment | 169.2400 | -1.75% | -10.84% |
Performance
| Año hasta la fecha | +0.98% | ||
|---|---|---|---|
| 6 Meses | +12.32% | ||
| Promedio móvil | -1.75% | ||
| 3 Años | -10.84% | ||
| 5 Años | +2.25% | ||
| 10 Años | +33.17% | ||
| Desde el principio | +408.23% | ||
| Año | |||
| 2023 | -3.35% | ||
| 2022 | -6.37% | ||
| 2021 | -6.73% | ||
| 2020 | +9.68% | ||
| 2019 | +14.53% | ||
| 2018 | -6.23% | ||
| 2017 | +33.23% | ||
| 2016 | -22.82% | ||
| 2015 | +0.53% | ||
